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Abstract 
Background: Propionibacterium freudenreichii is a food grade bacterium that has gained attention as a producer of 
appreciable amounts of cobalamin, a cobamide with activity of vitamin B12. Production of active form of vitamin is 
a prerequisite for attempts to naturally fortify foods with B12 by microbial fermentation. Active vitamin B12 is distin-
guished from the pseudovitamin by the presence of 5,6-dimethylbenzimidazole (DMBI) as the lower ligand. Genomic 
data indicate that P. freudenreichii possesses a fusion gene, bluB/cobT2, coding for a predicted phosphoribosyltrans-
ferase/nitroreductase, which is presumably involved in production of vitamin B12. Understanding the mechanisms 
affecting the synthesis of different vitamin forms is useful for rational strain selection and essential for engineering of 
strains with improved B12 production properties.
Results: Here, we investigated the activity of heterologously expressed and purified fusion enzyme BluB/CobT2. Our 
results show that BluB/CoBT2 is responsible for the biosynthesis of the DMBI base and its activation into α-ribazole 
phosphate, preparing it for attachment as the lower ligand of cobalamin. The fusion enzyme was found to be efficient 
in metabolite channeling and the enzymes’ inability to react with adenine, a lower ligand present in the pseudovita-
min, revealed a mechanism favoring the production of the active form of the vitamin. P. freudenreichii did not produce 
cobalamin under strictly anaerobic conditions, confirming the requirement of oxygen for DMBI synthesis. In vivo 
experiments also revealed a clear preference for incorporating DMBI over adenine into cobamide under both micro-
aerobic and anaerobic conditions.
Conclusions: The herein described BluB/CobT2 is responsible for the production and activation of DMBI. Fusing 
those two activities results in high pressure towards production of the true vitamin B12 by efficiently activating DMBI 
formed within the same enzymatic complex. This indicates that BluB/CobT2 is the crucial enzyme in the B12 biosyn-
thetic pathway of P. freudenreichii. The GRAS organism status and the preference for synthesizing active vitamin form 
make P. freudenreichii a unique candidate for the in situ production of vitamin B12 within food products.
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Background
Cobamides are corrinoid compounds and essential cofac-
tors synthesized uniquely by certain microorganisms. 
Their characteristic structure consists of a corrin ring 
with a central atom of cobalt and two axial ligands coor-
dinated to the cobalt, the so-called upper and lower 
ligands. Among cobamides, cobalamins, distinguished 
by the presence of 5,6-dimethylbenzimidazole (DMBI) as 
a lower ligand (Fig.  1a), are of special human nutritional 
value because of their activity of vitamin B12. Vitamin B12 
plays an important role in nucleotide synthesis as well as 
the metabolism of branched amino acids and odd-chain 
fatty acids. These molecules fulfill their role as cofactors 
in cytoplasmic methionine synthase and in mitochondrial 
methylmalonyl-CoA mutase, which are responsible for the 
methylation of homocysteine to methionine and the con-
version of methylmalonyl-CoA to succinyl-CoA, respec-
tively [1]. Cobalamin deficiency may lead to megaloblastic 
anemia and/or neuropsychiatric complications and, left 
untreated, can result in irreversible neurological disorder 
or even death [2]. DMBI as a lower ligand is crucial for the 
binding of cobalamin to the intrinsic factor, a glycoprotein 
responsible for its transport in the human gastrointestinal 
tract [1]. Due to the complexity and cost of the chemi-
cal synthesis of cobalamin, which requires approximately 
70 steps, its industrial production is exclusively through 
microbial fermentation, most commonly by Pseudomonas 
denitrificans and Propionibacterium freudenreichii [3].
In recent years the interest in fortification of food prod-
ucts in vitamin B12 by in  situ fermentation has been 
growing [4–8]. Vitamin B12 production by P. freudenre-
ichii is of special interest because of the Generally Rec-
ognized as Safe (GRAS) status of the organism, which 
allows its direct use in food and feed preparations [3]. 
Additionally, P. freudenreichii is an efficient producer, 
reaching cobalamin levels of 15 µg/mL [9], and further-
more, reportedly produces only trace amounts of pseu-
docobalamin [10]. In the pseudo form of the vitamin 
the lower ligand, adenine (Fig. 1a), renders its affinity to 
intrinsic factor 500-fold lower than cobalamin [11]. Some 
other GRAS organisms, mainly Lactobacillus, have also 
been reported to produce cobalamin [12–15]; however, it 
is questioned whether these species produce the active or 
the pseudo form of vitamin. Lactobacillus reuteri, which 
possesses the genes for B12 synthesis [13], was recently 
shown to produce pseudocobalamin exclusively due to its 
inability to incorporate other bases than adenine as the 
lower ligand of the cobamide [16, 17]. Streptomyces gri-
seus produces vitamin B12 for which the GRAS status has 
been granted (§184.1945), however since “Streptomyces 
spp. produce antibiotics and are therefore inappropriate 
for QPS (EFSA opinion 2008)” [18] the bacterium itself 
is not eligible for such status. With Lactobacilli unable 
to produce active vitamin B12, P. freudenreichii remains 
the only known producer with GRAS status granted by 
the FDA, and QPS granted by EFSA [18] allowing for its 
direct use in food and feed preparations.
The complete biosynthesis of cobalamin requires 
approximately 30 gene products [3], but it is the final 
steps of the pathway, namely production, activation and 
attachment of the lower ligand that decide whether the 
final product will be an active vitamin B12 or an analog. In 
aerobic and aerotolerant microorganisms, DMBI is syn-
thesized in an oxygen-dependent manner from reduced 
FMN by the action of the BluB enzyme [19–21], while 
in strict anaerobes gene cluster bzaABCDE has been 
recently associated with this function [22].
Synthesized DMBI is then activated by the CobT 
enzyme (CobU in aerobes) into α-ribazole-phosphate 
(α-RP) (Fig.  1c), preparing the lower ligand for attach-
ment to form the complete cobalamin molecule [23]. 
Recent studies determined that the selectivity of CobT 
is responsible for the range of lower ligands that can be 
attached to cobamide [17]. A study with seven CobT 
homologues from diverse organisms revealed that DMBI 
is a preferred substrate (with the exception of ArsAB of 
Veillonella parvula preferentially activating phenolic 
bases), although some of the homologues, such as CobT 
from L. reuteri, were unable to activate DMBI in  vivo 
[24]. In a related report, it was suggested that the ability 
to exclude certain lower ligands from incorporation into 
cobamides provides a mechanism preventing the produc-
tion of compounds that cannot be used by the organism 
[17].
The genetics of the complete cobalamin synthesis path-
way of P. freudenreichii have been previously studied and 
described [25–30]. The genome sequence of P. freuden-
reichii CIRM-BIA1 indicated that in this organism, the 
bluB gene is fused with cobT2 [30] resulting in a putative 
phosphoribosyl- transferase/nitroreductase that could 
both synthesize and activate DMBI for attachment into 
the cobalamin molecule. Although homologues of the 
fusion enzyme BluB/CobT2 have been found in multiple 
organisms on the genetic level, the enzyme has not yet 
been studied. In this work, we used the heterologously 
expressed and purified BluB/CobT2 enzyme of the type 
strain P. freudenreichii subsp. shermanii DSM 4902 to 
study its predicted novel ability to both synthesize and 
activate DMBI for attachment as a lower ligand in the 
final steps of biosynthesis of the active vitamin B12.
Results and discussion
Heterologous expression and purification of the BluB/
CobT2 enzyme
The bluB/cobT2 coding region [NCBI: NC_014215.1] 
was cloned in the pFN18A vector and transformed into 
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Fig. 1 Chemical structures. a Structure of cobalamin (1) molecule with the lower ligand DMBI (2) indicated by a dotted box. Adenine (3) is the 
lower ligand of the pseudovitamin form. R denotes possible upper ligands. b The reaction catalyzed by the BluB enzyme: formation of DMBI from 
FMNH2 (4). c The reaction catalyzed by the CobT enzyme: formation of α-RP (5) from DMBI and NaMN
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Escherichia coli KRX competent cells. From selected E. 
coli clones the inserts were sequenced to exclude altera-
tions in the sequence. The rhamnose-induced heter-
ologous expression and solubility of the recombinant 
protein were confirmed by SDS-PAGE (Fig. 2a). The pre-
dicted size for HaloTag-BluB/CobT2 protein is 100.4 kDa 
(34 kDa HaloTag + 66.4 kDa BluB/CobT2) and a band of 
corresponding molecular weight was detected in samples 
from E. coli whole-cell lysates and soluble fraction of the 
lysates obtained after induction (Fig. 2a). Following puri-
fication steps and tag removal the purified BluB/CobT2 
was obtained (Fig. 2b). The resulting BluB/CobT2 recom-
binant protein contains only four extra amino acids 
(SDNA) in its N-terminus, replacing the initial methio-
nine of native BluB/CobT2 of P. freudenreichii. The con-
centration of the obtained protein preparate was 0.4 mg/
ml.
Sequence analysis on BluB/CobT2
The gene product BluB/CobT2 [NCBI: CBL56167.1] 
from P. freudenreichii is a 626 amino acid protein, with 
the N-terminal part (aa 1–257) showing 40 and 35  % 
identity to previously characterized BluB enzymes from 
Sinorhizobium meliloti [19] and Bacillus megaterium 
DSM319 [21], respectively. The C-terminal part (aa 
294–626) of BluB/CobT2 shows ~30  % identity to pre-
viously characterized CobT enzymes from Salmonella 
enterica, L. reuteri, and S. meliloti, to ArsA from V. par-
vula [17] and to CobU from P. denitrificans [31]. The 
BluB/CobT2 regions homologous to BluB and CobT 
are interspaced by a proline-rich (23  %) stretch of ~34 
amino acids possibly forming a spacer region between 
the BluB and CobT2 domains. The proline-rich sequence, 
typical of non-helical protein linkers, can form extended 
rigid structures separating the protein domains [32], but 
“elbow bending” dynamics can also be observed [33]. 
Therefore, the linker could play a role in the dimeric 
interaction between the protein subunits, as domains 
BluB and CobT2 both have predicted dimeric interfaces 
[34]. Alternatively, the spacer region may be a remnant of 
the fusion event with no specific function. The ClustalW 
alignment of predicted BluB/CobT fusion proteins 
revealed that in organisms other than P. freudenreichii 
and Propionibacterium acidifaciens, the region separat-
ing the BluB and CobT domains, corresponding to aa 
258–293 in BluB/CoBT2, is shorter (Fig. 3).
According to a Blastp search, the closest homolog of 
BluB/CobT2 is P. acidifaciens, which encodes a 72  % 
identical protein [NCBI: WP_028706153.1]. Notably, 
BluB/CobT2 fusion proteins are not found in all mem-
bers of propionibacteria. Outside propionibacteria, a 
Blastp search revealed the highest homology against 
proteins from Propionimicrobium lymphophilum 
ACS-093-V-SCH5 and Austwickia chelonae, showing 
59 and 58  % identity with BluB/CobT2 of P. freuden-
reichii, respectively. Another Actinobacterium and 
known producer of vitamin B12, Streptomyces griseus, 
also posseses a fusion BluB/CobT enzyme, however it 
is additionally fused with a protein of unknown func-
tion at the N-terminus. S. griseus fusion protein shows 
34 % identity over the whole region of homology to P. 
freudenreichii BluB/CobT2. BluB/CobT appears to be 
rather widespread among Actinobacteria, but only a 
few isolated entries from other classes, including Spiro-
chaetia, Flavobacteria, Cytophagia and Deltaproteobac-
teria, were found.
BluB/CobT2 produces DMBI in presence of FMN and NADH
For enzymatic characterization, BluB/CobT2 of P. 
freudenreichii was heterologously produced in E. coli 
KRX and purified. The obtained recombinant BluB/
CobT2 was used in enzyme assays. Reactions performed 
with BluB/CobT2 included the formation of DMBI and 
its subsequent activation into α-ribazole-phosphate. We 
addressed these two predicted activities of BluB/CobT2 
both separately and jointly.
BluB is responsible for the formation of DMBI from 
FMNH2 in the presence of oxygen [19]. In order to 
reduce FMN to FMNH2, a flavin reductase, such as SsuE 
[19] and chemical reduction with NADH [19, 21] have 
been used previously. Here, DMBI formation by BluB/
CobT2 was studied in the presence of 100  µM FMN 
and 0, 20 or 40 mM of NADH. Preliminary experiments 
indicated that pH 8.5 was the most favorable for the 
reaction (data not shown). Liquid chromatography elec-
trospray ionization mass spectrometry (LC–ESI–MS) 
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HaloTag-BluB/CobT2 BluB/CobT2
Fig. 2 SDS-PAGE analysis of the purified recombinant BluB/CobT2 
enzyme. a Control of expression and solubility of the HaloTag-BluB/
CobT2: uninduced cells (lane C), whole-cell lysates (lane W), soluble 
fraction of the lysates (lane S). b Purified, tag-free BluB/CobT2 (lane E). 
Protein marker (lanes marked PL), stained with PageBlue
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was used to identify the reaction products. A compound 
with the expected m/z ratio for DMBI (m/z 147.3) was 
observed at the retention time of 4.05  min (Additional 
file 1: Figure S1). A commercial standard of DMBI, which 
appeared at the same m/z value and retention time, was 
used for the identification (Fig. 4a). Only trace amounts 
of DMBI were detected in the reaction without NADH, 
and the amount of DMBI increased with increasing 
NADH concentration (Table  1), indicating that the 
reduction of FMN by NADH was one of the limiting 
factors of DMBI production under the conditions used. 
S. enterica CobT has also been reported to catalyze the 
reaction of DMBI with NAD+ [35]. However, under the 
conditions used, we observed no peak corresponding to 
DMB-adenine dinucleotide (α-DAD) as a product of this 
reaction.
P.freudenreichii 241 AWSHKLPLDQVVMTDRWPDNG-PEPPVSALAGMAPAEPVESLITRPIPDDPSSVLWSDVHAPSPQQVVDARDKGEKLLTPPGSLGKLDQALDRLVAASG
P.acidifaciens 230 AWSHKLPLDEVIMADRWPENA-PRPPVSGLPGAAPSPETAPPAPVPGPD-PSSPLWSELAAPDQRRVVAARDRADDLLTPPGSLGRLDQALDRTVAVTG
P.acnes 231 GWSRRVPLSDVTLADRWPVSAQPEAPVSALRQTVRS-------------------------PDRHQVVAAHDDADQLLTPPGSLGLLDQTLDRVEAAGG
P.humerusii 231 GWSRRLPLDNVTLADRWPDTAQPEAPVSALRS-----------------------------PDRQQVVAAHDDADQLLTPPGSLGLLDQTLDRVEAAGG
P.lymphophilum 223 GWSKRLPLEEVVLRNRWPQSDEPSAPVSGLREDLAEK----------------YANMQVSAPGRLDVVGARDEADQLLTPPGSLGKFDQALDRLGAAMD
B.saxobsidens 220 GWSSRLSLDDVVLAERWPADGSPEAP-----------------------------VSHLAGPQPDAVVAGRDSGADLLAVPGSLGVLDRAVDRVLALPG
Dermacoccus sp. 193 SWSTKLPLEDVVLEERWPEGDGAPAQP----------------------------LSHLRAPDGDALVEAGDGADTLLAPPESLGILDRALNRVVATS-
A. chelonae 234 AWSRRLPLDEVVVYERWPQEDGRLPQP---------------------------PLHYLHSPDQSRVVSATDEADALLSPPGSLGVLDRALDRLVAAGA
Janibacter sp. 224 AWSKRMPLDDVVMHDRWAHEDAAP------------------------------PASHLDRLPQQSLVSATDDADGLLAPPESLGVLDRVVSRVEALGR
K. sinensis 228 AWSKRMPLEDVVMHDRWAGGRTVDGVPGASPTAPAS------------------HLGPRDHLPPSSLAAATDDADTLLAPPESLGVLDRAVSRVEALGR
Fig. 3 Alignment of the spacer regions. Part of the multiple sequence alignment of predicted BluB/CobT fusion proteins from different micro-
organisms showing the region between the BluB (aa 1–257) and CobT (aa 294–626) domains of BluB/CoBT2 of P. freudenreichii. The predicted 
spacer region is indicated by a line above the amino acid sequence. Protein sequences were obtained from NCBI Protein data base: P. freudenreichii 
[WP_013160556.1], P. acidifaciens [WP_028706153.1], P. acnes [WP_002548940.1], Propionibacterium humerusii [WP_007433757.1], P. lymphophilium 
[EPD33903], Blastococcus saxobsidens [WP_014375557.1], Dermacoccus sp. [WP_047312757.1], A. chelonae [WP_006501272.1], Janibacter sp. 
[WP_009778314.1] and Knoellia sinensis [WP_035916832.1] sequences were aligned by ClustalW and rendered using BOXSHADE
Fig. 4 Production and phosphoribosylation (activation) of DMBI by BluB/CobT2. a The LC chromatogram of the DMBI synthesis reaction containing 
BluB/CobT2, FMN and NADH after incubation for 48 h. b The LC chromatogram of two-step DMBI synthesis and activation reaction producing α-RP 
in the presence of the BluB/CobT2, FMN, NADH and NaMN after incubation for 48 h. The peaks were verified by MS/MS analysis. See also Additional 
file 1: Figure S1
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BluB/CobT2 activates DMBI into α‑RP in the presence 
of NaMN
CobT catalyzes the activation of the lower ligand base 
to form an α-ribosylated product. For the BluB/CobT2 
fusion enzyme, the lower ligand base DMBI is provided 
directly by the BluB part to feed the activation into α-RP 
by the CobT2 part of the enzyme. After confirming that 
BluB/CobT2 produces DMBI from FMNH2, we prepared 
a two-step reaction containing the substrates necessary 
for the biosynthesis of DMBI and its subsequent acti-
vation into α-RP, namely 100  µM FMN, 20 or 40  mM 
NADH and 200  µM of nicotinic acid mononucleotide 
(NaMN). LC–MS/MS analysis of the reaction products 
revealed a peak with the retention time of 2.75  min at 
m/z 359.1 that corresponds to α-RP (Fig. 4b). An MS/MS 
experiment on the ion at m/z 359.1 showed a fragment 
of 147.3, which corresponds to DMBI (Additional file 1: 
Figure  S1). DMBI was observed only in trace amounts, 
and this result was not affected by NADH concentration, 
suggesting efficient activation of the produced DMBI into 
α-RP by BluB/CobT2 (Table 1). It has been noted previ-
ously that benzimidazoles do not appear to be used for 
any other purposes than the lower ligands of cobamides 
[17]. The fusion of BluB with CobT allows the efficient 
use of produced DMBI, which is not required for any 
other processes in the cell.
In general, the fusion of two activities in a single poly-
peptide may be beneficial for the enzyme activity because 
of the increased efficiency of substrate transfer, protec-
tion of the intermediates, facilitation of the interactions 
between domains and establishment of a fixed stoichio-
metric ratio of the enzymatic activities of sequential 
reactions [36]. In our experiments the molar concentra-
tions of α-RP obtained from reaction coupling synthesis 
and activation of DMBI were ~2–3-fold higher than the 
DMBI concentrations measured from the DMBI synthe-
sis reaction alone (Table  1). This may indicate that the 
presence of NaMN stimulates the production of DMBI, 
possibly through imposing certain conformational 
changes on the BluB/CobT2 enzyme, resulting either in 
more efficient release of DMBI from the active site of the 
BluB part or an increase in BluB enzyme activity. The 
increased formation of α-ribazole-phosphate in the pres-
ence of NaMN relative to the formation of DMBI can be 
attributed to either of these mechanisms, leading to effi-
cient usage of the scarce substrates. This issue could be 
addressed further through crystallography studies.
Effect of substrate and environmental pH on DMBI 
activation by BluB/CobT2
It has been previously shown that semi-purified P. 
freudenreichii CobT requires NaMN or nicotinamide 
mononucleotide (NMN) in addition to DMBI for α-RP 
formation, with NaMN being a superior substrate pro-
ducing sevenfold more α-RP than NMN [10]. In the same 
study, the optimal pH range for the activity of semi-puri-
fied CobT was determined to be between 8.5 and 9.4 [10]. 
For the CobT enzymes of S. meliloti, S. enterica, L. reu-
teri, Desulfovibrio vulgaris, Dehalococcoides mccartyi and 
Veillonella parvula, pH 7.5 has been used as a reaction 
condition [24]. Here, we tested α-RP formation by BluB/
CobT2 from NaMN and exogenous DMBI at pH 8.5 and 
7.5, resulting in more than a threefold higher concentra-
tion of α-RP formed at pH 8.5 (Fig. 5). Subsequently, we 
compared the preference towards NaMN and NMN at 
pH 8.5. The amount of α-RP formed with NaMN as a sub-
strate was 6.4-fold higher than with NMN (Fig. 5), which 
is in accordance with previous results by Friedmann [10] 
and confirms that NaMN is the preferred substrate.
Table 1 Effect of  NADH concentration and  presence 
of NaMN on levels of DMBI and α-RP in reactions with the 
BluB/CobT2
The concentrations of DMBI and α-RP were measured following incubation of 
reactions for 48 h
The values reported are an average of three independent reactions, with 
standard deviation
NADH (mM) FMN (100 µM) FMN (100 µM) + NaMN 
(200 µM)
DMBI (nM) α‑RP (nM) DMBI (nM)
0 120 ± 6 – –
20 1362 ± 12 4458 ± 200 0.5 ± 0.2
40 2301 ± 9 5095 ± 215 2 ± 0.5
Fig. 5 Effect of substrate and pH on α-RP production by BluB/CobT2. 
The graph showing levels of α-RP formed by the BluB/CobT2 enzyme 
from DMBI and NaMN at pH 7.5 and 8.5 and α-RP formed from DMBI 
and NMN at pH 8.5
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Formation of Ade‑RP by BluB/CobT2
All of the CobT homologues studied thus far have had 
the ability to activate more than one type of base into 
a corresponding α-riboside phosphate, including dif-
ferent forms of benzimidazoles, purines and phenolic 
compounds, with the number and type of bases varying 
between enzymes from different organisms [24]. From 
the perspective of the biosynthesis of cobalamin, the acti-
vation of adenine is of particular interest because adenine 
activated into 7-α-d-ribofuranosyladenine 5′phosphate 
(Ade-RP) would serve as a substrate for the lower ligand 
of pseudocobalamin, resulting in competition between 
production of the active and pseudo-vitamin form. Pre-
vious studies using partially purified cell-extracts of P. 
freudenreichii have suggested that in this bacterium, the 
CobT-like activities do not include the activation of ade-
nine [10, 37]. Here, the activation of adenine was tested 
at pH 7.5 and 8.5 in the presence of NaMN, conditions 
that were found suitable for the activation of DMBI. 
A peak with the retention time of 1.25  min at m/z 348 
(Additional file 1: Figure S2) and with the same size was 
detected in reactions with and without adenine and in the 
sample with enzyme alone. This peak is most likely due 
to ATP used in the purification process of the enzyme, 
leading to residual AMP in the BluB/CobT2 prepara-
tion. Because 9-β-d-ribofuranosyladenine 5′phosphate 
(AMP) and Ade-RP are isomers (Fig.  6a), they cannot 
be distinguished by MS/MS. However, because the addi-
tion of adenine in the reaction did not increase the size 
of the Ade-RP/AMP peak, we conclude that BluB/CobT2 
does not react with adenine under the conditions tested. 
It was previously shown that the P. freudenreichii cell 
extracts form DMBI from FMN [38] and activate DMBI 
rather than adenine for attachment as a lower ligand into 
Fig. 6 BluB/CobT2 reaction product with adenine and NaMN was not detected. a The LC chromatograms of the 48 h reaction with BluB/CobT, 
adenine and NaMN (dotted) at pH 8.5 and of the BluB/CobT enzyme preparation (solid line). Chemical structures of isomers Ade-RP and AMP indis-
tinguishable by LC–MS/MS are shown. See also Additional file 1: Figure S2. b Part of the ClustalW alignment of CobT enzymes from S. enterica [NCBI: 
AAL20920.1], L. reuteri [NCBI: ABQ83934.1], S. meliloti [NCBI: CAC46463.1], P. denitrificans [Swiss-Prot: P29935.3], P. acidipropionici [NCBI: AFV88734.1] 
and P. freudenreichii [NCBI: CBL56167.1]. The amino acids corresponding to S80 and Q88 of S. enterica CobT and critical for lower ligand substrate 
specificity [17] are marked in bold. See also Additional file 1: Table S1
Page 8 of 12Deptula et al. Microb Cell Fact  (2015) 14:186 
cobamide [10] however, the mechanisms behind this 
preference remained obscure. One possible explanation 
was provided by structural studies of CobT from S. enter-
ica, which revealed that two polar amino acids stabilize 
adenine in the active site: serine at position 80 interacts 
with the amino group (N10) and glutamine at position 88 
interacts with the N3 ring nitrogen of adenine [17, 39]. 
Both of these groups are different in DMBI (Fig. 1a), and 
therefore mutations of S80 and Q88 show different pref-
erences of DMBI versus adenine activation. DMBI lacks 
the amino group and has a CH group instead of the N3 
ring nitrogen. Crofts et al. [17] showed that changing ser-
ine to phenylalanine at position 80 decreased the reac-
tion of CobT with adenine, while changing glutamine to 
methionine at position 88 decreased the reaction with 
adenine and furthermore increased the reaction with 
DMBI. The effect of these amino acid changes from 
hydrophilic to hydrophobic residues were found to be 
additive, as S. meliloti expressing the CobT enzyme of S. 
enterica carrying both mutations was found to produce 
the lowest amount of pseudo-cobalamin and the highest 
amount of cobalamin [17]. In the present study, multiple 
sequence alignment of P. freudenreichii BluB/CobT2 with 
other enzymes revealed the hydrophobic residues pheny-
lalanine and valine at positions corresponding to S80 and 
Q88 in S. enterica CobT (Fig.  6b). Similar organization 
is present in CobT proteins of S. meliloti and P. denitri-
ficans, two known producers of cobalamin, which carry 
hydrophobic phenylalanine and methionine in these 
positions (see also Additional file 1), further implying the 
role in substrate specificity. Considering that P. freuden-
reichii has been reported to produce small amounts of 
pseudocobalamin [38] but no activation of adenine by 
P. freudenreichii BluB/CobT2 was observed, the reaction 
leading to the pseudo form may be catalyzed by another, 
yet unidentified enzyme [10, 38]. Several bacteria pos-
sess another enzyme capable of activating cobamide 
bases, such as ArsA and ArsB, which are homologous 
to CobT, but activate phenolic bases as well [40], while 
species such as Propionibacterium acnes and Moorella 
thermoacetica have been reported to possess two seem-
ingly redundant CobT enzymes [41], which could have 
different substrate specificities. No such enzyme has 
been identified in P. freudenreichii thus far, therefore 
the importance of hydrophobic amino acids at positions 
corresponding to S80 and Q88 in S. enterica CobT for 
substrate specificity in BluB/CobT2 of P. freudenreichii 
should be addressed in targeted amino acid substitutions 
in future studies.
Cobamide production in vivo
Previous studies have revealed that the range of coba-
mides produced by a given organism in  vivo does not 
always correlate to the range observed with CobT 
enzymes in vitro. Furthermore, these studies have shown 
that the cobamide requirements of the organism largely 
determine the variety it produces [17, 24]. An attempt 
to distinguish between cobalamin and pseudocobalamin 
production under aerobic and strictly anaerobic condi-
tions was previously investigated in S. enterica, showing 
that the bacterium exclusively synthesizes pseudoco-
balamin under strictly anaerobic conditions and cobala-
min under microaerobic conditions [42]. This finding is 
consistent with the necessity of oxygen for the forma-
tion of DMBI in S. enterica [43], even though in that case 
the DMBI formation could have been non-enzymatic 
[44]. Knowing that P. freudenreichii is an aerotolerant 
anaerobe and that oxygen is required for the synthesis 
of DMBI, we decided to test cobamide formation in vivo 
under both anaerobic and microaerobic conditions.
As expected, the UHPLC (Ultra-high Performance 
Liquid Chromatography) analysis of cobamide extracts 
revealed no cobalamin but a small amount of pseudo-
cobalamin in samples in cultures grown under strictly 
anaerobic conditions and without exogenous DMBI 
(Fig.  7; Additional file  1: Figure  S3). In cultures grown 
under microaerobic conditions without exogenous 
DMBI, both cobalamin and pseudocobalamin were 
detected. In all culture conditions where exogenous 
DMBI (100  µM) was supplied, only cobalamin and no 
pseudocobalamin was detected, suggesting that DMBI 
synthesis was a limiting factor in cobalamin production 
under the growth conditions used. However, supple-
menting the growth medium with adenine (100 µM) did 
not increase the levels of pseudocobalamin formed, even 
under anaerobic conditions; instead, cobinamide, a coba-
mide missing the lower ligand, was detected (Additional 
file  1: Figure  S4), implying both that P. freudenreichii 
preferentially produces the active form of vitamin B12 and 
also that the production of DMBI is the limiting factor in 
this process.
Finally, we observed no peak corresponding to pseudo-
cobalamin in the samples from cells grown under condi-
tions where both bases were supplemented, indicating 
a preference towards incorporating DMBI over adenine 
and thereby a preference for the production of the active 
vitamin over the pseudovitamin in  vivo (Fig.  7). For S. 
meliloti, pseudocobalamin is not functionally equiva-
lent to cobalamin, as observed from the poor growth of 
mutant strains producing only the pseudo form of the 
vitamin in guided biosynthesis [17]. For P. freudenreichii, 
we observed that the cultures reached the same final cell 
densities under anaerobic conditions with only the pseu-
dovitamin produced, suggesting that while pseudocobal-
amin is not the preferred corrinoid it may, under some 
conditions, be able to substitute for cobalamin.
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Conclusions
The herein described fusion enzyme BluB/CobT2 
is responsible for the production and activation of 
DMBI for attachment as a lower ligand for cobalamin. 
Fusing those two activities results in high pressure 
towards the production of true vitamin B12 by activat-
ing DMBI produced within the same enzymatic com-
plex. Presence of NaMN was shown to stimulate the 
production of DMBI in  vitro, suggesting a regulatory 
mechanism securing efficient usage of the scarce sub-
strates. This efficiency, combined with the low ability 
to produce the pseudovitamin B12 form in  vivo, sug-
gests that P. freudenreichii may prefer the active vita-
min form as a cofactor for its own use. Our results 
indicate that BluB/CobT2 is the crucial enzyme in the 
B12 biosynthetic pathway, responsible for the produc-
tion of active vitamin over pseudovitamin. At present, 
P. freudenreichii is the only microorganism that has 
been both granted GRAS status and shown to produce 
the active form of vitamin B12, making it a unique can-
didate for the in  situ microbial fortification of food 
products.
Methods
Strains and culture conditions
The P. freudenreichii DSM 4902 was grown on PPA 
medium composed of 5.0  g tryptone (Sigma-Aldrich), 
10.0 g yeast extract (DIFCO Becton, Dickinson), 14.0 ml 
60  % w/w DL-sodium lactate (Sigma-Aldrich) per litre 
with/without 1.5 % agar, pH 7.3. For liquid cultures, the 
pH of the PPA medium was adjusted to 6.7 prior to auto-
claving. The strain was routinely grown at 30 °C in anaer-
obic jar on plates and under microaerobic condition in 
broth, unless stated otherwise.
Escherichia coli KRX clones carrying pFN18A-bluB/
cobT2 constructs were routinely grown in LB medium 
[45] with 100  µg/ml ampicillin, at 37 or 25  °C, with 
275 rpm shaking.
Overexpression and purification of BluB/CobT2
BluB/CobT2 was expressed in E. coli KRX cells using 
the Flexi® Vector pFN18A (Promega, Wisconsin, USA). 
Genomic DNA from P. freudenreichii was isolated as 
described previously [46]. The bluB/cobT2 coding region 
(NC_014215.1) was PCR amplified using primer 1 and 
Control
Ad
DMBI
Ad+DMBI
Ad
Control
DMBI
Ad+DMBI
1
1
2
2
1 2
1 2
2
2
U
A
a b
Fig. 7 Cobamide production by P. freudenreichii in vivo. The UHPLC chromatograms of cobamides extracted and purified from cultures grown 
under anaerobic (a) and microaerobic (b) conditions, with and without addition of DMBI (100 µM) and/or adenine (Ad; 100 µM). Identity of pseudo-
cobalamin (peak 1) and cobalamin (peak 2) were confirmed by LC–MS/MS. See also Additional file 1: Figure S3
Page 10 of 12Deptula et al. Microb Cell Fact  (2015) 14:186 
primer 2 with SgfI and PmeI restriction sites (Additional 
file  1: Table  S2), and cloned as a SgfI-PmeI fragment in 
the pFN18A vector (Promega, Wisconsin, USA). E. coli 
KRX clones carrying pFN18A-bluB/cobT2 constructs 
were screened by PCR using primer 3 and primer 4. 
Plasmid from a selected clone was further verified by 
sequencing of the insert at the DNA sequencing labora-
tory (Institute of Biotechnology, University of Helsinki).
The heterologous expression and purification of the 
BluB/CobT2 enzyme were performed according to the 
HaloTag protein expression and purification system 
manuals (Promega), with 50 mM NaCl, 1 mM DTT, and 
0.5 mM EDTA in the purification buffer and 2 mM ATP, 
10 mM MgCl and 0.005 % IGEPAL CA-630 added for the 
binding step at 4  °C for 16  h. The HaloTag protein was 
removed with HaloTEV protease (Promega, Wisconsin, 
USA) by incubating the protein preparation for 12  h at 
4  °C, followed by 90  min incubation at room tempera-
ture. The purity of the recombinant BluB/CobT2 protein 
was confirmed by SDS-PAGE, stained with PageBlue 
(Fermentas, Thermo Fisher Scientific, Delaware, USA) 
and the concentration determined using a NanoDrop 
1000 (Thermo Fisher Scientific, Delaware, USA. The pro-
tein was stored in aliquots at −20 °C until used.
Sequence analyses
Similarity searches for BluB/CobT2 were performed 
using BLAST at the National Center for Biotechnology 
Information. Protein sequence alignments were per-
formed with the program ClustalW via the ClustalW web 
service at the European Bioinformatics Institute [47].
BluB/CobT enzyme activity reactions and the LC–MS 
method
All the enzyme activity reactions were conducted in trip-
licate, using 5 µM of the BluB/CobT2 enzyme. The BluB 
reaction was performed with 1 mM DTT, 100 µM FMN, 
and 20 or 40 mM NADH in 90 mM Tris–HCl at pH 8.5. 
CobT activity with DMBI was tested with 1  mM DTT, 
100 µM DMBI, and 200 µM NaMN or NMN in 90 mM 
Tris–HCl at pH 7.5 or 8.5. For the measurement of CobT 
activity with adenine, DMBI was replaced by adenine 
(100  µM) in the reaction, and NMN was omitted. The 
two-step BluB-CobT reaction was performed with 1 mM 
DTT, 100 µM FMN, 20 or 40 mM NADH, and 200 µM 
NaMN in 90  mM Tris–HCl at pH 7.5 or 8.5. Control 
reactions lacking the enzyme were also performed, and 
in the case of BluB activity, a reaction condition lack-
ing NADH was also tested. For the reactions containing 
FMN, dark tubes were used. All the reactions were incu-
bated at room temperature, protected from direct light. 
After the indicated incubation time, the reactions were 
stopped by the addition of 6.5 % TCA.
The LC–ESI–MS consisted of a Waters Acquity UPLC 
I class binary solvent manager, sample manager and col-
umn thermostat (maintained at 25 °C) and a Waters Xevo 
TQ-S triple quadrupole mass spectrometer (Waters, 
Milford, MA, USA). A Waters Acquity UPLC BEH C18 
(2.1 ×  50  mm, 1.7  μm) column was used at a flow rate 
of 0.3 mL/min. The mobile phase consisted of 0.1 % for-
mic acid in water (A) and 0.1 % formic acid in methanol 
(B). The linear gradient elution for DMBI and α-RP was 
as follows: 0–6.0 min: 5 % B to 50 % B, 6.0–6.5 min: 50 % 
B to 100 % B, 6.5–8.0 min: 100 % B, 8.0–8.1 min: 100–5 % 
B, 8.1–10.0  min: 5  % B. The linear gradient elution for 
adenine and adenosine monophosphate was as follows: 
0–1.7 min: 0.5 % B to 1 % B, 1.7–2.2 min: 1 % B to 5 % B, 
2.2–2.4 min: 5 % B to 100 % B, 2.4–3.5 min: 100 % B, 3.5–
3.6 min: 100–0.5 % B, 3.6–5.0 min: 0.5 % B. The injection 
volume was 1 μL. The mass spectrometer was operated in 
the positive electrospray ionization mode: capillary volt-
age was 0.5 kV, source offset 50 V and cone voltage 30 V. 
The source temperature was 150 °C, the desolvation tem-
perature 350 °C and the desolvation gas flow was 800 L/h. 
The LC–MS analyses were conducted using selected 
reaction monitoring (SRM): ion transitions and collision 
energies were as follows: DMBI 147 → 132, 25 eV; α-RP 
359 → 147, 20 eV; adenine 136 → 119, 20 eV; and adeno-
sine monophosphate 348 → 136, 25 eV.
Stock solutions (5  mM) were prepared by dissolving 
the analytes in deionized water. Working standard solu-
tions were prepared by diluting the stock solutions to 
the appropriate concentrations. The standard solutions 
were used to prepare a calibration curve with the follow-
ing concentration levels: 0.1, 0.2, 1.0, 2.5, 5.0, 10, 50, 100, 
500, 1000, 5000 and 7500  nM. DMBI and adenine were 
quantitated against authentic standard compounds. Due 
to the lack of standard compounds, α-RP and ade-RP 
were quantified using DMBI and adenine as reference 
standards.
Cobamide production in vivo and the UHPLC‑UV/MS 
method
Fresh colonies of P. freudenreichii DSM 4902 were inocu-
lated into 30 mL of PPA broth supplemented with 5 µg/
mL of cobalt chloride and either DMBI (100  µM) or 
adenine (100 µM), or a combination of both DMBI and 
adenine. Additionally, control cultures with neither ade-
nine nor DMBI were simultaneously inoculated. The cul-
tures were incubated statically under normal atmosphere 
(microaerobic condition) or in an anaerobic chamber 
(Don Whitley Scientific, West Yorkshire, UK) for 7 days. 
For each condition, three biological replicate cultures 
were used. Cells were harvested by centrifugation, and 
the cobamides were analyzed as previously described 
[6]. Briefly, the cobamides were extracted, in their cyano 
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form, from bacterial pellets by boiling with 10  mL of 
extraction buffer (pH 4.5) containing 100  µL of 1  % 
NaCN. After purification through immunoaffinity col-
umns (Easy Extract; R-Biopharma, Glasgow, Scotland), 
the extracts were analyzed by UHPLC on a Waters UPLC 
system (Waters, Milford, MA, USA) with separation on 
a Waters Acquity HSS T3 C18 column (2.1 ×  100  mm, 
1.8 µm) at a flow rate of 0.32 mL/min and with UV detec-
tion by a photo diode array (PDA) detector at 361  nm. 
The mobile phase was a gradient flow of 0.025  % trif-
luoroacetic acid in water and 0.025 % trifluoroacetic acid 
in acetonitrile [6]. The injection volume was 10 μL. Coba-
mides were identified with their retention times and their 
absorption spectra, and quantified using a calibration 
curve prepared with a set of cyanocobalamin standards 
with concentrations ranging from 0.015‒1.5  ng/µL. The 
flowthrough from the immunoaffinity purification was 
also analyzed with UHPLC and MS for the presence of 
cobamides and cobinamide (See Additional file 1: Figure 
S4).
To confirm the identity of the cobamides and cobina-
mide, the extracts were analyzed using a high resolution 
quadrupole time-of-flight mass spectrometer (QTOF, 
Synapt G2-Si; Waters, Milford, MA, USA) with an elec-
trospray ionization interface to the UHPLC system. The 
mobile phase for MS contained 0.1 % formic acid instead 
of 0.025  % trifluoroacetic acid. The mass spectrometer 
was operated in positive electrospray ionization mode 
with a scanning range set for ions with m/z of 50–1500. 
Parent ions were collected and fragmented (MS/MS) 
using argon as a collision gas. The capillary voltage was 
0.5 kV, the sampling cone voltage 40 V and the source off-
set 80 V. The source temperature was 150 °C, desolvation 
temperature 600 °C, desolvation gas flow 1000 L/h, nebu-
lizer gas flow 6.5 bar, and cone gas flow 50 L/h. The trap 
collision energy ramp was 15‒90 eV, trap gas flow 2 mL/
min and scan time 0.2  s. A lock-spray mass correction 
standard (leucine-enkephalin; m/z 556.2771) was intro-
duced every 10 s.
Additional file
Additional file 1. This file consists of four supplemental figures and two 
supplemental tables. Figures S1 and S2 present additional information 
on reactions shown in Figs. 1 and 4, including structures of compounds, 
retention times and fragmentation spectra. Table S1 groups CobT 
homologues from various microorganisms and their activities. More 
detailed findings of bioinformatic analysis of amino acids in positions 
corresponding to S80 and Q88 of CobT from Salmonella enterica (SeCobT) 
as predictors of the activity are also provided. Figure S3 presents UHPLC-
UV (361 nm) chromatogram of cobamide extract after purification on 
immunoaffinity column and the UHPLC-MS/MS spectra of peaks identified 
as cobalamin and pseudobobalamin. Figure S4 shows UHPLC-UV (361 nm) 
chromatograms of the flowthrough which passed through the immunoaf-
finity columns and the UHPLC-MS/MS spectra of cobinamides. Table S2 
lists primers used for PCR amplification of the bluB/cobT2 coding region.
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